Immunohistochemical analyses demonstrated that hAG-2, hAG-3, and ER protein expression was detected in 48 (83%), 43 (74%), and 34 (59%), respectively, of 58 breast cancer sections. This evidence concerns the gene AGR3 and breast cancer.